Baricitinib versus tocilizumab in mechanically ventilated patients with COVID-19: a nationwide cohort study

Crit Care. 2024 Aug 29;28(1):282. doi: 10.1186/s13054-024-05063-2.
No abstract available

Publication types

  • Letter
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Azetidines* / administration & dosage
  • Azetidines* / therapeutic use
  • COVID-19
  • COVID-19 Drug Treatment*
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Purines / therapeutic use
  • Pyrazoles* / therapeutic use
  • Respiration, Artificial*
  • Sulfonamides / therapeutic use

Substances

  • tocilizumab
  • baricitinib
  • Antibodies, Monoclonal, Humanized
  • Pyrazoles
  • Azetidines
  • Purines
  • Sulfonamides